Millennium Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.7M Buy
705,461
+151,787
+27% +$3.63M 0.01% 1750
2025
Q4
$14.8M Sell
553,674
-929,561
-63% -$22.2M 0.01% 1863
2025
Q3
$31.7M Buy
1,483,235
+1,414,315
+2,052% +$33.4M 0.02% 1210
2025
Q2
$1.49M Sell
68,920
-29,025
-30% -$540K ﹤0.01% 4125
2025
Q1
$1.63M Sell
97,945
-1,020,416
-91% -$18.5M ﹤0.01% 3976
2024
Q4
$20.5M Sell
1,118,361
-934,758
-46% -$15.1M 0.02% 1496
2024
Q3
$31.6M Sell
2,053,119
-884,595
-30% -$14.8M 0.03% 1155
2024
Q2
$47.7M Buy
2,937,714
+832,370
+40% +$13.4M 0.04% 825
2024
Q1
$38.9M Buy
2,105,344
+340,666
+19% +$8.44M 0.03% 997
2023
Q4
$55.3M Sell
1,764,678
-648,786
-27% -$15.5M 0.05% 734
2023
Q3
$50.3M Buy
2,413,464
+1,925,692
+395% +$52.3M 0.05% 703
2023
Q2
$11.7M Sell
487,772
-1,264,241
-72% -$28.1M 0.01% 1859
2023
Q1
$33M Buy
1,752,013
+549,684
+46% +$10.5M 0.04% 958
2022
Q4
$19.1M Buy
1,202,329
+833,651
+226% +$13M 0.02% 1484
2022
Q3
$6.03M Sell
368,678
-485,599
-57% -$7.86M 0.01% 2710
2022
Q2
$12M Sell
854,277
-232,612
-21% -$4.34M 0.02% 1809
2022
Q1
$26.3M Buy
1,086,889
+483,876
+80% +$11.7M 0.03% 1123
2021
Q4
$14.1M Buy
603,013
+592,403
+5,583% +$11.9M 0.02% 1784
2021
Q3
$176K Sell
10,610
-111,321
-91% -$2.15M ﹤0.01% 6186
2021
Q2
$2.97M Buy
121,931
+110,131
+933% +$2.49M ﹤0.01% 3452
2021
Q1
$304K Sell
11,800
-355,311
-97% -$15.6M ﹤0.01% 5204
2020
Q4
$19.6M Sell
367,111
-224,421
-38% -$11.1M 0.03% 1084
2020
Q3
$24.4K Sell
591,532
-237,900
-29% -$10.3M 0.06% 667
2020
Q2
$40.2M Buy
829,432
+521,586
+169% +$25M 0.1% 375
2020
Q1
$13M Sell
307,846
-680,467
-69% -$28M 0.05% 681
2019
Q4
$42.3M Sell
988,313
-32,551
-3% -$1.42M 0.08% 447
2019
Q3
$36.7M Buy
1,020,864
+517,029
+103% +$15.7M 0.08% 435
2019
Q2
$13.5M Buy
503,835
+197,674
+65% +$5.05M 0.03% 1045
2019
Q1
$8.22M Sell
306,161
-599,255
-66% -$14M 0.01% 1406
2018
Q4
$14.6M Buy
905,416
+486,673
+116% +$9.45M 0.03% 890
2018
Q3
$8.69M Sell
418,743
-261,881
-38% -$4.12M 0.01% 1413
2018
Q2
$10.4M Buy
680,624
+19,266
+3% +$344K 0.01% 1291
2018
Q1
$14.9M Buy
661,358
+574,577
+662% +$15.9M 0.02% 1071
2017
Q4
$2.61M Buy
86,781
+25,112
+41% +$803K ﹤0.01% 2114
2017
Q3
$2.32M Sell
61,669
-527,253
-90% -$17.2M ﹤0.01% 2095
2017
Q2
$16.4M Buy
588,922
+550,491
+1,432% +$16.4M 0.03% 769
2017
Q1
$1.32M Sell
38,431
-1,885,725
-98% -$66.6M ﹤0.01% 2233
2016
Q4
$55.5M Buy
1,924,156
+1,764,872
+1,108% +$46.7M 0.12% 230
2016
Q3
$5.07M Buy
159,284
+76,187
+92% +$2.58M 0.01% 1333
2016
Q2
$2.7M Sell
83,097
-252,858
-75% -$8.46M 0.01% 1628
2016
Q1
$9.39M Sell
335,955
-122,830
-27% -$2.68M 0.03% 873
2015
Q4
$16.4M Sell
458,785
-336,240
-42% -$11.8M 0.04% 650
2015
Q3
$26.3M Sell
795,025
-255,004
-24% -$10.6M 0.06% 450
2015
Q2
$44M Buy
1,050,029
+538,507
+105% +$20.8M 0.09% 295
2015
Q1
$16.7M Buy
511,522
+467,412
+1,060% +$16.1M 0.03% 757
2014
Q4
$1.4M Buy
44,110
+16,841
+62% +$478K ﹤0.01% 2251
2014
Q3
$675K Buy
+27,269
New +$638K ﹤0.01% 2555
2014
Q2
Sell
-20,800
Closed -$434K 3338
2014
Q1
$506K Buy
+20,800
New +$526K ﹤0.01% 2610
2013
Q4
Sell
-137,120
Closed -$3.23M 3410
2013
Q3
$3.77M Sell
137,120
-86,333
-39% -$1.8M 0.02% 1279
2013
Q2
$4.06M Buy
+223,453
New +$3.08M 0.02% 1153

Other funds holding ACAD